Cancer and VTE

 

 

A review of published studies on VTE therapy in patients with cancer in real world.

López-Núñez JJ, Trujillo-Santos J, Monreal M. Management of venous thromboembolism in patients with cancer. J Thromb Haemost. 2018 Sep 23. doi: 10.1111/jth.14305

 

In cancer patients with VTE, myocardial infarction or ischemic stroke carry a similar mortality than PE recurrences

Brenner B, Bikdeli B, Tzoran I, Madridano O, López-Reyes R, Suriñach JM, Blanco-Molina Á, Tufano A, Núñez JJL, Trujillo-Santos J, Monreal M; RIETE Investigators. Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism. Am J Med. 2018 Sep;131(9):1095-1103. doi: 10.1016/j.amjmed.2018.04.037. Epub 2018 May 26.

 

Natural history of VTE in patients with pancreatic cancer

Frere C, Trujillo-Santos J, Font C, Sampériz Á, Quintavalla R, González-Martínez J, Vázquez FJ, Lima J, Farge D, Monreal M; RIETE Investigators. Clinical Course of Venous Thromboembolism in Patients with Pancreatic Cancer: Insights from the RIETE Registry. Thromb Haemost. 2018 Jun;118(6):1119-1122. doi: 10.1055/s-0038-1642009. Epub 2018 Apr 21.

 

Validation of a prognostic score for hidden cancer

. Jara-Palomares L, Otero R, Jimenez D, Praena-Fernandez JM, Font C, Falga C, Soler S, Riesco D, Verhamme P, Monreal M; RIETE Registry. Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism. PLoS One. 2018 Mar 20;13(3):e0194673. doi: 10.1371/journal.pone.0194673. eCollection 2018.

 

Vitamin K antagonists in cancer patients with VTE

. Chai-Adisaksopha C, Iorio A, Crowther MA, de Miguel J, Salgado E, Zdraveska M, Fernández-Capitán C, Nieto JA, Barillari G, Bertoletti L, Monreal M; RIETE investigators. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism. Am J Med. 2018 Apr;131(4):430-437. doi: 10.1016/j.amjmed.2017.11.042. Epub 2017 Dec 20.

 

Ottawa VTE risk score in a cohort of patients with cancer

. Alatri A, Mazzolai L, Font C, Tafur A, Valle R, Marchena PJ, Ballaz A, Tiraferri E, Font L, Monreal M, Riete Investigators T. Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry. Thromb Haemost. 2017 Jul 26;117(8):1630-1636. doi: 10.1160/TH17-02-0116. Epub 2017 May 18.

 

Venous thromboembolism in radiation therapy cancer patients

. Guy JB, Bertoletti L, Magné N, Rancoule C, Mahé I, Font C, Sanz O, Martín-Antorán JM, Pace F, Vela JR, Monreal M; RIETE investigators. Venous thromboembolism in radiation therapy cancer patients: Findings from the RIETE registry. Crit Rev Oncol Hematol. 2017 May;113:83-89. doi: 10.1016/j.critrevonc.2017.03.006. Epub 2017 Mar 9.

 

Predictors of active cancer thromboembolic outcomes

. Tafur AJ, Caprini JA, Cote L, Trujillo-Santos J, Del Toro J, Garcia-Bragado F, Tolosa C, Barillari G, Visona A, Monreal M; RIETE Investigators. Predictors of active cancer thromboembolic outcomes. RIETE experience of the Khorana score in cancer-associated thrombosis. Thromb Haemost. 2017 Jun 2;117(6):1192-1198. doi: 10.1160/TH16-11-0840. Epub 2017 Mar 9.

 

Venous thromboembolism and cancer: gender differences

. Martín-Martos F, Trujillo-Santos J, Del Toro J, Bura-Riviere A, Lorenzo A, Barillari G, Soler S, Mahè I, Sahuquillo JC, Monreal M; RIETE Investigators. Gender differences in patients with venous thromboembolism and five common sites of cancer. Thromb Res. 2017 Mar;151 Suppl 1:S16-S20. doi: 10.1016/S0049-3848(17)30061-0.

 

Clinical factors affecting the rates of VTE and cancer patients

. Trujillo-Santos J, Martos FM, Font C, Farge-Bancel D, Rosa V, Lorenzo A, Barrón M, Lorente MA, Pedrajas JM, Monreal M. Analysis of clinical factors affecting the rates of fatal pulmonary embolism and bleeding in cancer patients with venous thromboembolism. Heliyon. 2017 Jan 16;3(1):e00229. doi: 10.1016/j.heliyon. 2016.e00229. eCollection 2017 Jan.

 

Venous thromboembolism according to cancer site

. Mahé I, Chidiac J, Bertoletti L, Font C, Trujillo-Santos J, Peris M, Pérez Ductor C, Nieto S, Grandone E, Monreal M; RIETE investigators. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site. Am J Med. 2017 Mar;130(3):337-347. doi: 10.1016/j.amjmed.2016.10.017. Epub 2016 Nov 22

 

Prediction score for occult cancer in patients with VTE

. Jara-Palomares L, Otero R, Jimenez D, Carrier M, Tzoran I, Brenner B, Margeli M, Praena-Fernandez JM, Grandone E, Monreal M; RIETE Investigators. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE. Chest. 2017 Mar;151(3):564-571. doi: 10.1016/j.chest.2016.10.025. Epub 2016 Nov 1.

 

Anticoagulant therapy in cancer patients with a pulmonary embolism

. Peris M, Jiménez D, Maestre A, Font C, Tafur AJ, Mazzolai L, Xifre B, Skride A, Dentali F, Monreal M; RIETE Investigators. Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism. Eur Respir J. 2016 Nov;48(5):1360-1368. doi: 10.1183/13993003.00779-2016. Epub 2016 Sep 22.

 

Catheter-related thrombosis, thromboembolism and bleeding

. Valle R, Monreal Bosch M; RIETE Investigators. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis. J Vasc Surg Venous Lymphat Disord. 2015 Jul;3(3):243-50.e1. doi: 10.1016/j.jvsv.2015.03.002. Epub 2015 Jun 15.

 

VTE in patients with glioblastoma multiforme

. Portillo J, de la Rocha IV, Font L, Braester A, Madridano O, Peromingo JA, Apollonio A, Pagán B, Bascuñana J, Monreal M and the RIETE Investigations. Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE Registry. Thromb Res 2015 Dec; 136(6): 1199-203.

 

Disseminated intravascular coagulation in patients with cancer and VTE

. Spiezia L, Campello E, Trujillo-Santos J, Piovella C, Brenner B, Monreal M, Prandoni P and the RIETE Investigators. The impact of disseminated intravascular coagulation on the outcome of cancer patients with venous thromboembolism. Blood Coagul Fibrinolysis 2015 Sep; 26(6): 709-11.

 

Fatal PE and fatal bleeding

. Farge-Bancel D, Trujillo-Santos J, Debourdeau P, Bura-Riviere A, Rodriguez-Beltrán EM, Nieto JA, Peris ML, Zeltser D, Mazzolai L, Hij A, Monreal M and the RIETE Investigators. Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism. Medicine (Baltimore) 2015 Aug; 94(32): e1235.

 

Gender differences in patients with cancer and VTE

. Martín-Martos F, Trujillo-Santos J, Barrón M, Vela J, Marchena PJ, Braester A, Hij A, Hernández-Blasco L, Verhamme P, Monreal M and RIETE investigators. Gender differences in cancer patients with acute venous thromboembolism. Thromb Res 2015 Feb; 135 Suppl 1: S12-5.

 

Immobilization or recent surgery in patients with cancer and VTE

. Trujillo-Santos J, Gussoni G, Gadelha T, Sánchez Muñoz-Torrero JF, Barrón M, López L, Ruiz-Ruiz J, Fernández-Capitán C, Lorente M, Monreal and the RIETE investigators. Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism. Thromb Res 2014 May; 133 Suppl 2: S29-34.

 

VTE in patients with cancer and renal insuficence

. Kooiman J, den Exter PL, Cannegieter SC, le Cessie S, Del Toro J, Sahuquillo JC, Pedrajas JM and Huisman MV. Impact of chronic kidney disease on the risk of clinical outcomes in patients with cancer-associated venous thromboembolism during anticoagulant treatment. J Thromb Haemost 2013 Nov; 11(11): 1968-76.

 

Predictors of death in cancer with VTE

. Gussoni G, Frasson S, La Regina M, Di Micco P, Monreal M; for the RIETE Investigators. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE Registry.Thromb Res 2013 Jan; 131(1): 24-30.

 

Predicting low risk patients of PE

. Exter PL, Gómez V, Jiménez D, Trujillo-Santos J, Muriel A, Huisman MV, Monreal M; for the RIETE investigators. A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer. Chest 2013 Jan; 143(1): 138-145.

 

Unsuspected pulmonary embolism in cancer patients

. Soler S, Delgado C, Ballaz A, Cisneros E, Malý R, Babalis D, Monreal M and the RIETE Investigators. Unsuspected pulmonary embolism in patients with cancer. Thromb Res 2012 Apr; 129 Suppl 1: S16-9.

 

Long-term treatment with LMWH for VTE in cancer patients

. Marchena PJ, Nieto JA, Guil M, García-Bragado F, Rabuñal R, Boccalon H, Trujillo-Santos J, Monreal M and the RIETE Investigators. Long-term therapy with low-molecular-weight heparin in cancer patients with venous thromboembolism. Thromb Haemost 2012 Jan; 107(1): 37-43.

 

Prevention of VTE

. Trujillo-Santos J, Fernández-Capitán C, Rosa V, Gutiérrez MR, Oribe M, Mahe I, Monreal M and the RIETE Investigators. Prevention of venous thromboembolism in patients with cancer in Spain. J Coagul Disord 2011 Oct; 3(1): 64-68.

 

30-day mortality in women with cancer and VTE

. Trujillo-Santos J, Casas JM, Casado I, Samperiz AL, Quintavalla R, Sahuquillo JC, Monreal M, and the RIETE Investigators. Thirty-day mortality rate in women with cancer and venous thromboembolism. Findings from the RIETE Registry. Thromb Res 2011 Feb;127 Suppl 3:S1-4.

 

Bleeding during treatment of VTE

. Trujillo-Santos J, Nieto J A, Ruiz-Gamietea A, López-Jiménez L, García-Bragado F, Quintavalla R, Monreal M for the RIETE Investigators. Bleeding Complications associated with anticoagulant therapy in patients with cancer. Thromb Res 2010 Apr; 125 Suppl 2:S58-61.

 

Prediction of recurrences or bleeding in women with cancer

. Trujillo-Santos J, Ruiz-Gamietea A, Luque JM, Samperiz AL, García-Bragado F, Todolí JA, Monreal M, for the RIETE Investigators. Predicting recurrences or major bleeding in women with cancer and venous thromboembolism. Findings from the RIETE Registry. Thromb Res 2009; 123 Suppl 2: S10-5.

 

Leukocytosis and outcomes

. Trujillo-Santos J, Di Micco P, Iannuzzo M, Lecumberri R, Guijarro R, Madridano O, Monreal M for the RIETE Investigators. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008 Nov; 100(5): 905-11.

 

Recurrences and bleeding in patients with solid cancer and VTE

. Prandoni P, Trujillo-Santos J, Surico T, Dalla Valle F, Piccioli A, Monreal M for the RIETE Investigators. Recurrent thromboembolism and major bleeding during oral anticoagulant therapy in patients with solid cancer: findings from the RIETE Registry. Haematologica 2008 Sep; 93(9):1432-4.

 

Prediction of outcomes in cancer patients

. Trujillo-Santos J, Nieto JA, Tiberio G, Piccioli A, Di Micco P, Prandoni P, Monreal M for the RIETE Investigators. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008 Sep; 100(3): 435-9.

 

Hidden cancer in patients with VTE

. Trujillo-Santos J, Prandoni P, Rivron-Guillot K, Román P, Sánchez R, Tiberio G, Monreal M and the RIETE Investigators. Clinical outcome in patients with venous thromboembolism and hidden cancer: findings from the RIETE Registry. J Thromb Haemost 2008 Feb; 6(2): 251-55.

 

RIETE lessons in patients with cancer and VTE

. Monreal M, Prandoni P, Di Micco P, Barba R, Trujillo-Santos J, Rivron-Guillot K, Decousus H. Lessons learned from Cancer/VTE Registries: Report from RIETE. Thromb Res 2007; 120 (2): S62-S63.

 

Upper extremity thrombosis in cancer

. Monreal M, Muñoz FJ, Rosa V, Romero C, Román P, Di Micco P, Prandoni P. Upper extremity DVT in oncological patients: analysis of risk factors. Data from the RIETE Registry. Exp Oncol 2006 Sep; 28(3): 245-7.

 

Fatal PE and fatal bleeding in cancer

. Monreal M, Falgá C, Valdés M, Suárez C, Gabriel F, Tolosa C, Montes J for the RIETE Investigators. Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE Registry. J Thromb Haemost 2006 Sep; 4(9):1950-6.

 

VTE and outcome in cancer patients

. Monreal M, Falgá C, Vilaseca B, Suárez C, Gabriel F, Tolosa C, Montes J for the RIETE investigators.Clinical outcomes in cancer patients with concurrent venous thromboembolism: findings from the RIETE Registry. Haematologica Reports 2005 Oct; 1(9): 64-65.

About us

The RIETE Registry is the world’s largest database on patients with venous thromboembolism (VTE).

RIETE Registry is a Fundación Fuente project

Follow us

Last update

September 2018

 

 

RIETE 2018 © 2018 All rights reserved